Vachellia leucophloea (Roxb.) Maslin, Seigler & Ebinger is a tree that fits into the Fabaceae family. V. leucophloea has been applied to heal including bronchitis, diabetes, high cholesterol, leprosy, and snakebite. Phytochemicals including betulinic acid-3-O-β-d-maltoside; Δ7-avenasterol; leucophleol; leucophleoxol; and leucoxol; have been isolated from bark, root, and leaf of this plant species. This systematic review article purposes to evaluate, outline, and document the bioactivities associated with available researches involving V. leucophloea. PubMed, Semantic Scholar, Scopus, ScienceDirect, and Web of Science electronic records were employed to find the applicable available works from 1900 to June 2021. So far, in vivo and in vitro scientific evidence is presently existing for several bioactivities. To date, antidiabetic, antidiarrheal, antihyperlipidemic, antipyretic, wound healing, antibacterial, antidementia, antifungal, antiinflammatory, antioxidant, antiplatelet, and bronchorelaxant activities have been scientifically demonstrated for different parts of this plant species. Only an antidiabetic compound {(-)-Fisetinidol-(4α,8)-[(-)-fisetinidol-(4α,6)]-(+)-catechin} has been isolated from this plant species. Further in vitro, in vivo, and clinical studies of various traditional medicinal uses of V. leucophloea should be investigated as well as the bioactive compounds should be identified.
Vachellia leucophloea Acacia leucophloea Fabaceae antioxidant activity bioactivity
Not Applicable
Not Applicable
This work received no funding. The authors are grateful to their family members for their support to deliver this work.
Not Applicable
Birincil Dil | İngilizce |
---|---|
Konular | Yapısal Biyoloji , Eczacılık ve İlaç Bilimleri, Klinik Kimya |
Bölüm | Review Articles |
Yazarlar | |
Proje Numarası | Not Applicable |
Yayımlanma Tarihi | 29 Haziran 2021 |
Kabul Tarihi | 28 Haziran 2021 |
Yayımlandığı Sayı | Yıl 2021 Cilt: 2 Sayı: 1 |